Tema Oncology ETF (NYSE: CANC) — Company Overview, News & Financial Data
Tema Oncology ETF offers exposure to companies involved in cancer prevention, treatment, and supportive care.
CANC Tema Oncology ETF
Company profile
Tema Oncology ETF
Tema Oncology ETF (NASDAQ:CANC) provides investors with exposure to companies actively involved in the fight against cancer. Launched in 2023, CANC invests in a diversified portfolio of global businesses focused on cancer prevention, diagnosis, treatment, and supportive care. This includes pharmaceutical companies developing innovative drugs, medical device manufacturers, and companies providing diagnostic tools and services. By investing in CANC, investors can gain potential access to the long-term growth prospects of the rapidly evolving oncology sector.
Snapshot
Public USOwnership
2023Year founded
18Employees
New York, United StatesHead office
Loading Map...
Global footprint
Operations
All Locations
New York City, US
Products and/or services of Tema Oncology ETF
- Investment in groundbreaking cancer treatment technologies, focusing on innovative therapies.
- Portfolio diversification across various oncology sectors, ensuring balanced exposure to the cancer care continuum.
- Research and development funding aimed at supporting early-stage oncology companies.
- Educational programs designed to increase investor awareness about oncology advancements and investment opportunities.
- Strategic collaborations with biopharmaceutical companies to accelerate the development of new cancer treatments.
- Sustainable investment strategies that prioritize long-term growth in the oncology field.